Abvc Biopharma (ABVC) Short-term Investments (2021 - 2026)
Abvc Biopharma's Short-term Investments came in at $62,420 for Q2 2026, down 4.3% from $65,211 a year earlier but up 0.4% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Short-term Investments (2021 - 2026) Analysis & Trends
At the end of FY2025, Abvc Biopharma's Short-term Investments was $64,354, down 0.6% from FY2024.
- Short-term Investments carries a four-year compound annual growth rate of -12.2% (FY2021 to FY2025).
- Going back by year, Short-term Investments was $64,736 in FY2024 (-18.4%), $79,312 in FY2023 (+4.6%), $75,797 in FY2022 (-29.9%) and $108,147 in FY2021.
- The five-year range for quarterly Short-term Investments is $62,185 (Q1 2026) to $111,320 (Q3 2021).
- Year-over-year, Short-term Investments has declined for seven consecutive quarters, with an average decline of 7.6% over the last eight quarters.
- The fastest year-over-year change in Short-term Investments over five years came in Q4 2023 (growth of 4.6%), and the weakest in Q3 2022 (a decline of 30.3%).
- Business Quant data shows ABVC's Short-term Investments at $62,185 (Q1 2026), $64,354 (Q4 2025) and $65,175 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn |
| 10 | Abvc Biopharma | 26.80 Mn | 27.48 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 62,420.00 |
| Mar 31, 2026 | 62,185.00 |
| Dec 31, 2025 | 64,354.00 |
| Sep 30, 2025 | 65,175.00 |
| Jun 30, 2025 | 65,211.00 |
| Mar 31, 2025 | 65,052.00 |
| Dec 31, 2024 | 64,736.00 |
| Sep 30, 2024 | 70,809.00 |
| Jun 30, 2024 | 75,683.00 |
| Mar 31, 2024 | 75,916.00 |
| Dec 31, 2023 | 79,312.00 |
| Sep 30, 2023 | 68,521.00 |
| Jun 30, 2023 | 76,787.00 |
| Mar 31, 2023 | 78,014.00 |
| Dec 31, 2022 | 75,797.00 |
| Sep 30, 2022 | 77,583.00 |
| Jun 30, 2022 | 82,755.00 |
| Mar 31, 2022 | 95,553.00 |
| Dec 31, 2021 | 108,147.00 |
| Sep 30, 2021 | 111,320.00 |
API Access
Abvc Biopharma Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();